ATE421094T1 - Screeningverfahren für kombinationen von biologischen verbindungen - Google Patents
Screeningverfahren für kombinationen von biologischen verbindungenInfo
- Publication number
- ATE421094T1 ATE421094T1 AT04790957T AT04790957T ATE421094T1 AT E421094 T1 ATE421094 T1 AT E421094T1 AT 04790957 T AT04790957 T AT 04790957T AT 04790957 T AT04790957 T AT 04790957T AT E421094 T1 ATE421094 T1 AT E421094T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- cancer
- combinations
- screening process
- biological compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50885903P | 2003-10-07 | 2003-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421094T1 true ATE421094T1 (de) | 2009-01-15 |
Family
ID=34465087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04790957T ATE421094T1 (de) | 2003-10-07 | 2004-10-07 | Screeningverfahren für kombinationen von biologischen verbindungen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1687642B1 (de) |
| AT (1) | ATE421094T1 (de) |
| CA (1) | CA2549579A1 (de) |
| DE (1) | DE602004019135D1 (de) |
| DK (1) | DK1687642T3 (de) |
| WO (1) | WO2005038465A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006128740A2 (en) * | 2005-06-02 | 2006-12-07 | Centelion | Anti-vascular methods and therapies employing lysyl oxidase inhibitors |
| US8900619B2 (en) * | 2006-08-24 | 2014-12-02 | Boston Scientific Scimed, Inc. | Medical devices for the release of therapeutic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2092468T3 (es) * | 1988-01-22 | 1996-12-01 | Zymogenetics Inc | Metodos para producir analogos de receptores secretados. |
| DE69222637T2 (de) * | 1991-05-10 | 1998-02-26 | Rhone Poulenc Rorer Int | Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase |
| US6180632B1 (en) * | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| WO2002072578A2 (en) * | 2001-03-08 | 2002-09-19 | Millennium Pharmaceuticals | (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
-
2004
- 2004-10-07 AT AT04790957T patent/ATE421094T1/de not_active IP Right Cessation
- 2004-10-07 CA CA002549579A patent/CA2549579A1/en not_active Abandoned
- 2004-10-07 DK DK04790957T patent/DK1687642T3/da active
- 2004-10-07 DE DE602004019135T patent/DE602004019135D1/de not_active Expired - Lifetime
- 2004-10-07 WO PCT/EP2004/012185 patent/WO2005038465A2/en not_active Ceased
- 2004-10-07 EP EP04790957A patent/EP1687642B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005038465A2 (en) | 2005-04-28 |
| DK1687642T3 (da) | 2009-05-11 |
| EP1687642A2 (de) | 2006-08-09 |
| EP1687642B1 (de) | 2009-01-14 |
| DE602004019135D1 (de) | 2009-03-05 |
| CA2549579A1 (en) | 2005-04-28 |
| WO2005038465A3 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148985A (en) | 2-aminopyridine analogs as glucokinase activators | |
| ATE372341T1 (de) | Inhibitoren von mitotischem kinesin | |
| MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
| EP1481077A4 (de) | Mitotische kinesin-hemmer | |
| DE60231439D1 (de) | Mitotische kinesinhemmer | |
| EP1765362A4 (de) | Zusammensetzungen und verfahren zur behandlung von neovaskulären erkrankungen | |
| MXPA04002070A (es) | Compuestos de indazol sustituidos para el tratamiento de la inflamacion. | |
| DE60329990D1 (de) | Mitotische kinesin-hemmer | |
| DE60329756D1 (de) | Mitotische kinesin-hemmer | |
| CY1108927T1 (el) | Αναστολεις μιτωτικης κινεσινης | |
| ATE502941T1 (de) | Hemmer der menschlichen phosphatidyl-inositol-3- kinase delta | |
| ATE356804T1 (de) | Inhibitoren von mitotischem kinesin | |
| EA201000016A1 (ru) | Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| ATE521608T1 (de) | Glucokinaseaktivatoren | |
| MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
| ATE343575T1 (de) | Azaoxoindol derivate als trk protein kinase hemmstoffe zur behandlung von krebs und chronischem schmerz | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| ATE266031T1 (de) | Verfahren und verbindungen zur behandlung proliferativer erkrankungen | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| EA200800011A1 (ru) | Тиенопиримидиновые и тиенопиридиновые модуляторы киназы | |
| ATE424208T1 (de) | Proteinkinaseinhibitoren | |
| TW200740808A (en) | Inhibiteurs de proteines kinases | |
| EP1507778A4 (de) | Polzcyclische carbonsäureamide mit antitumorwirkung | |
| DE602004019135D1 (de) | Screeningverfahren für Kombinationen von biologischen Verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |